These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
322 related items for PubMed ID: 16516988
1. Novel potent agonist [(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 and antagonist [Nphe1,(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 of nociceptin/orphanin FQ receptor. Peng YL, Chang M, Dong SL, Li W, Han RW, Fu GX, Chen Q, Wang R. Regul Pept; 2006 May 15; 134(2-3):75-81. PubMed ID: 16516988 [Abstract] [Full Text] [Related]
2. [(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor. Carrà G, Rizzi A, Guerrini R, Barnes TA, McDonald J, Hebbes CP, Mela F, Kenigs VA, Marzola G, Rizzi D, Gavioli E, Zucchini S, Regoli D, Morari M, Salvadori S, Rowbotham DJ, Lambert DG, Kapusta DR, Calo' G. J Pharmacol Exp Ther; 2005 Mar 15; 312(3):1114-23. PubMed ID: 15509719 [Abstract] [Full Text] [Related]
4. In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor. Rizzi A, Spagnolo B, Wainford RD, Fischetti C, Guerrini R, Marzola G, Baldisserotto A, Salvadori S, Regoli D, Kapusta DR, Calo G. Peptides; 2007 Jun 15; 28(6):1240-51. PubMed ID: 17532097 [Abstract] [Full Text] [Related]
5. [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor. Calo G, Rizzi A, Rizzi D, Bigoni R, Guerrini R, Marzola G, Marti M, McDonald J, Morari M, Lambert DG, Salvadori S, Regoli D. Br J Pharmacol; 2002 May 15; 136(2):303-11. PubMed ID: 12010780 [Abstract] [Full Text] [Related]
6. In vitro and in vivo pharmacological characterization of the nociceptin/orphanin FQ receptor ligand Ac-RYYRIK-ol. Gündüz O, Rizzi A, Baldisserotto A, Guerrini R, Spagnolo B, Gavioli EC, Kocsis L, Magyar A, Benyhe S, Borsodi A, Calò G. Eur J Pharmacol; 2006 Jun 06; 539(1-2):39-48. PubMed ID: 16682024 [Abstract] [Full Text] [Related]
7. Quantitative study of [(pF)Phe4,Arg14,Lys15]nociceptin/orphanin FQ-NH2 (UFP-102) at NOP receptors in rat periaqueductal gray slices. Kuo CJ, Liao YY, Guerrini R, Calo' G, Chiou LC. Eur J Pharmacol; 2008 Jan 28; 579(1-3):110-5. PubMed ID: 17976580 [Abstract] [Full Text] [Related]
8. [Nphe1,Arg14,Lys15]N/OFQ-NH2 is a competitive antagonist of NOP receptors in the periaqueductal gray. Chiou LC, Liao YY, Guerrini R, Calo' G. Eur J Pharmacol; 2005 May 16; 515(1-3):47-53. PubMed ID: 15896734 [Abstract] [Full Text] [Related]
10. The nociceptin receptor antagonist [Nphe1,Arg14,Lys15]nociceptin/orphanin FQ-NH2 blocks the stimulatory effects of nociceptin/orphanin FQ on the HPA axis in rats. Leggett JD, Harbuz MS, Jessop DS, Fulford AJ. Neuroscience; 2006 Sep 15; 141(4):2051-7. PubMed ID: 16784820 [Abstract] [Full Text] [Related]
11. Pharmacological profile of the cyclic nociceptin/orphanin FQ analogues c[Cys10,14]N/OFQ(1-14)NH2 and c[Nphe1,Cys10,14]N/OFQ(1-14)NH2. Kitayama M, Barnes TA, Carra G, McDonald J, Calo G, Guerrini R, Rowbotham DJ, Smith G, Lambert DG. Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec 15; 368(6):528-37. PubMed ID: 14598020 [Abstract] [Full Text] [Related]
12. Nociceptin/orphanin FQ stimulates human monocyte chemotaxis via NOP receptor activation. Trombella S, Vergura R, Falzarano S, Guerrini R, Calo G, Spisani S. Peptides; 2005 Aug 15; 26(8):1497-502. PubMed ID: 15922491 [Abstract] [Full Text] [Related]
13. UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor. Calo G, Guerrini R, Rizzi A, Salvadori S, Burmeister M, Kapusta DR, Lambert DG, Regoli D. CNS Drug Rev; 2005 Aug 15; 11(2):97-112. PubMed ID: 16007234 [Abstract] [Full Text] [Related]
14. Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: pharmacological and genetic evidences. Rizzi A, Nazzaro C, Marzola GG, Zucchini S, Trapella C, Guerrini R, Zeilhofer HU, Regoli D, Calo' G. Pain; 2006 Sep 15; 124(1-2):100-8. PubMed ID: 16697109 [Abstract] [Full Text] [Related]
15. Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120. Fischetti C, Rizzi A, Gavioli EC, Marzola G, Trapella C, Guerrini R, Petersen JS, Calo G. Peptides; 2009 Feb 15; 30(2):248-55. PubMed ID: 18992780 [Abstract] [Full Text] [Related]
16. N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands. Guerrini R, Caló G, Lambert DG, Carrá G, Arduin M, Barnes TA, McDonald J, Rizzi D, Trapella C, Marzola E, Rowbotham DJ, Regoli D, Salvadori S. J Med Chem; 2005 Mar 10; 48(5):1421-7. PubMed ID: 15743186 [Abstract] [Full Text] [Related]
17. Activation of the nociceptin/orphanin FQ receptor reduces bronchoconstriction and microvascular leakage in a rabbit model of gastroesophageal reflux. D'Agostino B, Marrocco G, De Nardo M, Calò G, Guerrini R, Gallelli L, Advenier C, Rossi F. Br J Pharmacol; 2005 Mar 10; 144(6):813-20. PubMed ID: 15685213 [Abstract] [Full Text] [Related]